The coexistence of diabetes and hypertension drives the cardio-kidney-metabolic system into a vicious cycle. Therefore, intensive blood pressure control (IBP) is crucial for diabetic patients complicated with hypertension.Studies have shown that diabetic patients with hypertension have a significantly higher risk of adverse cardiovascular events compared to normotensive diabetic individuals. These two conditions jointly accelerate the […]
Category: Diabetes Treatment
Breaking Diagnostic Bottlenecks Through Multidimensional Clinical Interventions for CKM
In recent years, significant progress has been made in multidimensional clinical interventions for Cardio-Kidney-Metabolic (CKM) syndrome. Professor Pan Qi from Beijing Hospital emphasizes that the core advancement lies in breaking the limitations of single-disease treatment, integrating novel medications, technological tools, and multidisciplinary collaboration to achieve a paradigm shift from disease control to systemic protection.First, regarding […]
Reconstructing Chronic Disease Management Models: The Integrated CKM Management Concept and Implementation Pathways
Amid the rapid advancement of modern medicine, cardiovascular diseases, kidney diseases, and metabolic disorders have emerged as major global health challenges. These conditions do not exist in isolation; instead, they are interrelated and interactive, forming a complex disease spectrum known as the Cardio-Kidney-Metabolic Syndrome (CKM). Traditional single-disease management models are no longer sufficient to meet […]
Long-Acting Basal Insulin Weekly Formulation — Icodec Insulin Offers More Treatment Options for Patients with Type 2 Diabetes (T2DM)
The advent of long-acting basal insulin weekly formulations represents a landmark milestone. While ensuring hypoglycemic efficacy and safety, it significantly reduces the injection burden, providing more treatment options for patients with type 2 diabetes (T2DM).At present, icodec insulin, the world’s first insulin weekly formulation, has been included in China’s medical insurance catalogue, and an increasing […]
What Should a Diabetic Patient Do If Having a Heart Attack?
I. First Aid First: Stabilize the ConditionIn an emergency, take first aid measures immediately.Call the emergency number, keep the patient calm, and avoid any movement or emotional stimulation to buy time for professional rescue.Administer oxygen to improve myocardial hypoxia. Adjust the body position according to the specific situation: Emergency medication is also essential to relieve […]
How to Treat Diabetic Patients with Gastric Diseases?
For diabetic patients complicated with gastric diseases, blood glucose control and gastrointestinal protection should be carried out simultaneously. The treatment course usually lasts more than 8 weeks. Such patients need to adjust their hypoglycemic regimen, optimize dietary structure, and treat gastric lesions at the same time.
How to Improve Poor Peripheral Circulation in Diabetes?
Poor peripheral circulation in diabetes can be improved through daily care, medical treatment, physical therapy and other methods.
Professor Zhang Jie: The Core Mechanism of Insulin Degludec/Aspart and Its Significance for Chinese Patients with Diabetes
Professor Zhang Jie from the National Center for Geriatrics, Beijing Hospital, states that insulin degludec/insulin aspart has demonstrated consistent and significant HbA1c reduction and low hypoglycemia risk worldwide. The core behind this therapeutic consistency lies in its unique pharmacological design.Insulin degludec/insulin aspart is a soluble dual-component insulin formulation, composed of 70% ultra-long-acting insulin degludec and […]
Post-Marketing Multinational Real-World Studies of Insulin Degludec/Insulin Aspart: Confirming Its Efficacy and Safety
In the era of evidence-based medicine, randomized controlled trials (RCTs) provide robust evidence for new drug approval, while real-world evidence (RWE) helps reveal the actual performance of drugs in complex and diverse clinical settings. Since its global launch, insulin degludec/insulin aspart has not only demonstrated favorable efficacy and safety in registration trials but also continues […]
Treatment Strategies for Normocalcemic Primary Hyperparathyroidism (NPHPT)
According to Professor Jiaqiang Zhou from Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, the treatment strategies for normocalcemic primary hyperparathyroidism (NPHPT) vary among different patient groups and mainly include the following aspects:I. Monitoring and ManagementFor asymptomatic patients without target-organ damage, regular monitoring is recommended: Treatment plans should be adjusted promptly if disease […]